SPYG Spdr Series Trust Spdr Portfolio S&P 500 Growth Etf
- 89.140
- +0.970+1.10%
Nike Put Options Volume Jump as Company Outlook Signals Difficult Path Ahead
Tech Titans Triumph: The Top 10 Billionaires Who Made Big Gains In 2024
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Apple Working on Doorbell, Lock Device With Facial Recognition Capabilities: Report
Apple's Home Strategy Has Struggled. Could That Change?
Ultraman angrily confronts Musk: he is just a "bully" who likes to "fight" with opponents.
Altman believes that Musk's hostility towards OpenAI largely stems from its success. He also mentioned that Musk had "high-profile" arguments with Jeff Bezos and Bill Gates.
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Short Sellers Targeting Major Auto Stocks, Growing Their Positions - S3 Partners
Deal Dispatch: Honeywell, Textron And Soho House Are Making M&A Moves
Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.
① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.
OpenAI Project to Improve ChatGPT Behind Schedule as Costs Soar: Report
As Quantum Computing Stocks Soar, Wall Street Analysts Take Bullish Stance
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Novo Nordisk Raises Expectations for Eli Lilly After CagriSema Slipup
Notable Analyst Calls This Week: Tesla, Zoom and Micron Stocks Among Top Picks
Did Novo-Nordisk A/S fall, leaving Eli Lilly and Co to dominate the weight loss medication market?
Novo-Nordisk A/S faced a "Waterloo," with new drug effects falling short of expectations, causing a dramatic drop in stock prices. The landscape of the weight loss drug market is quietly changing; will Eli Lilly and Co become a sole oligopoly?
Tesla Cybertruck Units Reportedly Found With Cell Dent Issues: EV Giant Starts Replacing Battery Packs
Options Market Statistics: Tesla's Rollercoaster Week Ends with Friday Sell-Off; Options Pop
Spdr Series Trust Spdr Portfolio S&P 500 Growth Etf To Go Ex-Dividend On December 23rd, 2024 With 0.17136 USD Dividend Per Share
Tesla Model Y Could Lose Bestselling Title In Europe To This Non-EV Car